Open AccessEstimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System
Author(s) -
Márcio Debiasi,
Tomás Reinert,
Rafael Aliosha Kaliks,
Gilberto Amorim,
Maira Caleffi,
Carlos Eduardo Peres Sampaio,
Gustavo dos Santos Fernandes,
Carlos H. Barrios
Publication year - 2017
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2016.005678
Subject(s) - medicine , breast cancer , cancer , public health , estimation , oncology , gynecology , environmental health , family medicine , pathology , management , economics
Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic tumors treated in the public health system in Brazil do not have access to trastuzumab. This study aimed to estimate the impact of the lack of access to anti-HER2 therapies on the mortality of these patients.